loadpatents
name:-0.0090181827545166
name:-0.0084130764007568
name:-0.0096960067749023
O'Neill; Kim Leslie Patent Filings

O'Neill; Kim Leslie

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Neill; Kim Leslie.The latest application filed is for "use of car and bite technology coupled with an scfv from an antibody against human thymidine kinase 1 to specifically target tumors".

Company Profile
14.13.14
  • O'Neill; Kim Leslie - Provo UT US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrophage CAR (MOTO-CAR) in immunotherapy
Grant 11,352,439 - O'Neill , et al. June 7, 2
2022-06-07
Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
App 20210330770 - O'Neill; Kim Leslie ;   et al.
2021-10-28
Transgenic Macrophages, Chimeric Antigen Receptors, and Associated Methods
App 20210207096 - O'Neill; Kim Leslie
2021-07-08
Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
Grant 11,052,138 - O'Neill , et al. July 6, 2
2021-07-06
Modified Macrophages And Macrophage Precursors And Associated Methods
App 20210052643 - O'Neill; Kim Leslie
2021-02-25
Transgenic macrophages, chimeric antigen receptors, and associated methods
Grant 10,889,803 - O'Neill January 12, 2
2021-01-12
Use of car and bite technology coupled with an ScFv from an antibody against human thymidine kinase 1 to specifically target tumors
Grant 10,828,355 - O'Neill , et al. November 10, 2
2020-11-10
Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
Grant 10,821,162 - O'Neill , et al. November 3, 2
2020-11-03
Transgenic Macrophages, Chimeric Antigen Receptors, And Associated Methods
App 20200002676 - O'Neill; Kim Leslie
2020-01-02
Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumors
Grant 10,434,153 - O'Neill , et al. O
2019-10-08
Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
App 20190091309 - O'Neill; Kim Leslie ;   et al.
2019-03-28
Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
App 20190070276 - O'Neill; Kim Leslie ;   et al.
2019-03-07
Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
App 20190070277 - O'Neill; Kim Leslie ;   et al.
2019-03-07
Macrophage CAR (MOTO-CAR) In Immunotherapy
App 20170166657 - O'Neill; Kim Leslie ;   et al.
2017-06-15
Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
Grant 9,267,948 - O'Neill , et al. February 23, 2
2016-02-23
Compositions And Methods For Cancer Management Using Antibodies Binding To Nucleotide Salvage Pathway Enzymes And Complexes Thereof
App 20110176996 - O'Neill; Kim Leslie ;   et al.
2011-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed